A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue Virus
about
Dengue Fever: Causes, Complications, and Vaccine StrategiesEndothelial cells in dengue hemorrhagic feverAntiviral activity of geneticin against dengue virus.Allosteric Inhibition of the NS2B-NS3 Protease from Dengue VirusA potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surfaceDengue research opportunities in the AmericasProtection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vector.A porcine adenovirus with low human seroprevalence is a promising alternative vaccine vector to human adenovirus 5 in an H5N1 virus disease modelBioinformatics in new generation flavivirus vaccines.Dengue vaccines: state of the art.Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever.Utility, limitations, and future of non-human primates for dengue research and vaccine developmentMechanistic study of broadly neutralizing human monoclonal antibodies against dengue virus that target the fusion loop.Dengue vaccines: recent developments, ongoing challenges and current candidates.A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritisNext-generation dengue vaccines: novel strategies currently under development.Selection and Characterization of DNA Aptamers Targeting All Four Serotypes of Dengue VirusesViral kinetics of primary dengue virus infection in non-human primates: a systematic review and individual pooled analysisAn alphavirus vector-based tetravalent dengue vaccine induces a rapid and protective immune response in macaques that differs qualitatively from immunity induced by live virus infection.Enhanced induction of intestinal cellular immunity by oral priming with enteric adenovirus 41 vectors.Oral Modeling of an Adenovirus-Based Quadrivalent Influenza Vaccine in Ferrets and Mice.Serotype-specific host responses in rhesus macaques after primary dengue challenge.New insights on adenovirus as vaccine vectors.Dengue virus photo-inactivated in presence of 1,5-iodonaphthylazide (INA) or AMT, a psoralen compound (4'-aminomethyl-trioxsalen) is highly immunogenic in mice.A molecular evaluation of dengue virus pathogenesis and its latest vaccine strategies.The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease.Treatment of dengue fever.Challenges for the formulation of a universal vaccine against dengue.Dengue epidemiology and pathogenesis: images of the future viewed through a mirror of the past.Adenoviral vector-based strategies against infectious disease and cancer.Recombinant dengue 2 virus NS3 protein conserves structural antigenic and immunological properties relevant for dengue vaccine design.A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates.Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccines.A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity.Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus.The necessity and quandaries of dengue vaccine development.
P2860
Q26700082-F2A1BF19-6F3D-4846-A7DA-C97DD9F19DFEQ26825663-30003E6C-0366-4A4D-B6BF-D7D5A0CC2B35Q27488716-DE0A6FDD-AD8E-41DF-A34A-8D742B8F209DQ27680467-C058BA85-8185-4B95-9A91-36935DC3DA5BQ27681319-BC7C5329-900C-4E5B-815C-36D64A7CBDD4Q28656204-18252903-7655-4D90-94C8-27372F2AF004Q33768646-31C4B994-5BC8-4A86-A6E5-45D0F264B238Q33778607-1D1CD1D4-64D6-4AC2-8762-B61E5740A312Q33839001-7A7DA0C8-9EEB-44EE-8784-2F3D5B4E18F1Q34109652-23AB94DC-C616-4CF1-A1C7-BB2372E5BC9FQ34202440-06BB1364-1F8A-49A0-820B-AF248806E57BQ34238916-7FFAF9DB-6A56-421B-A34E-675E6377EB57Q34306877-0020FA8B-E7AB-4647-A4A4-483E8EDA7F82Q34367194-1D6BA274-BD01-42EB-9A2B-A93F0EA94C8FQ34703785-2B2D75DE-C6CD-4FA3-B1F2-CC67E4B165EEQ35491639-CD053313-17F1-44BB-8C9F-3D96D1FE28E4Q35674292-3CE3BB6A-4700-471A-8359-0CC33C888F59Q36082908-81E1FD03-65FA-4B11-A408-42CB8134D713Q36667964-B10FC6B6-3BC3-46B2-89E3-A13CC991A675Q37033283-B300AB3F-C3F6-45E7-9422-6D7885C26826Q37056528-9F476AF3-56D7-4EBF-876F-91B3AEB1796DQ37372592-6E7D13EB-CC35-4DB5-98D8-008C084C6E3FQ37513550-83949397-BA63-4A8C-9CDB-04D5D1A8C2ECQ37694855-8C062509-CE37-45EE-BAD1-1B0AC976DF6FQ37812291-236181C0-36C2-4265-8D5F-50537077DBCFQ37903445-4084BDA5-60CA-4559-8205-AA61F920AD69Q38032553-B023AE48-3146-4949-9F6C-8EA1A36C7902Q38121757-D03202F0-5D8B-47D8-A190-CA99A9582487Q38614539-4700A12F-1840-4199-ADF8-799475A32BC9Q38814885-1D0AEA53-31F2-47F3-8284-0DB150A6ECCAQ39187784-CBE96E58-F375-47AB-B839-0381CAB5B5A5Q40255696-0CF8624F-8123-40E5-8DB7-DD9DBB8A6601Q40265040-88AC3153-A282-4E52-8895-C74F59E3210BQ40379142-4545DA3C-C950-4915-A397-7675A711FD86Q41242033-24663005-5B74-4FF5-9971-F754387B5D4FQ42710655-6AA6A0F6-C83E-4113-B180-AC692BE84AB3
P2860
A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue Virus
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A Tetravalent Dengue Vaccine B ...... Four Serotypes of Dengue Virus
@ast
A Tetravalent Dengue Vaccine B ...... Four Serotypes of Dengue Virus
@en
A Tetravalent Dengue Vaccine B ...... Four Serotypes of Dengue Virus
@nl
type
label
A Tetravalent Dengue Vaccine B ...... Four Serotypes of Dengue Virus
@ast
A Tetravalent Dengue Vaccine B ...... Four Serotypes of Dengue Virus
@en
A Tetravalent Dengue Vaccine B ...... Four Serotypes of Dengue Virus
@nl
prefLabel
A Tetravalent Dengue Vaccine B ...... Four Serotypes of Dengue Virus
@ast
A Tetravalent Dengue Vaccine B ...... Four Serotypes of Dengue Virus
@en
A Tetravalent Dengue Vaccine B ...... Four Serotypes of Dengue Virus
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
A Tetravalent Dengue Vaccine B ...... Four Serotypes of Dengue Virus
@en
P2093
Curtis Hayes
Danher Wang
David H Holman
Jan Woraratanadharm
John Y Dong
Kanakatte Raviprakash
Karla Block
Kevin Porter
P2860
P304
P3181
P356
10.1128/JVI.02724-07
P577
2008-07-01T00:00:00Z